Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2010-11-23

Clinical Trial Update: Surveying The Outcomes Of Lubiprostone (The STOOL Study) in Nursing Home Residents

View source ↗

Summary

The STOOL study evaluating lubiprostone for constipation in nursing home residents has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LUBIPROSTONE (lubiprostone)

Snippet

Sponsor: Synergy Health Solutions | Conditions: Constipation | Status: WITHDRAWN